EUVIMEDEUVIMED entdecken
Multizentrische Studie

Global adoption of TRI-SCORE digital tools for the risk stratification of patients with tricuspid regurgitation

Julien Dreyfus, David Messika-Zeitoun

Archives of Cardiovascular Diseases · 2026-10 · 119 (10) · 637-640

DOI: 10.1016/j.acvd.2026.04.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Archives of Cardiovascular Diseases, 2026-10. Verfasst von Julien Dreyfus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Centre Cardiologique du Nord, 93200 Saint-Denis, France. Electronic address: dreyfusjulien@yahoo.fr. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Decision Support Techniques, Mobile Applications, Tricuspid Valve. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Edwards Lifesciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The TRI-SCORE is a dedicated risk-stratification tool for patients with isolated severe tricuspid regurgitation (TR) that is freely accessible via a web-based platform or mobile application. AIMS: To evaluate the global uptake of the TRI-SCORE and to describe the clinical characteristics of patients considered for intervention. METHODS: We collected all TRI-SCORE calculations and related parameters entered by users into the web-based calculator or mobile application between June 2024 and June 2025, along with the users' geographic location. The clinical profiles derived from these data were compared with those of the TRIGISTRY cohort. RESULTS: Overall, 36,001 calculations were recorded across 117 countries, with 83% performed through the web-based platform. Most patients were aged≥70 years (70%), 58% were women and 70% had atrial fibrillation or flutter. TR was functional in 73% of cases. Patients were generally severely symptomatic (58% in New York Heart Association class III-IV, 58% with right heart failure signs) and many presented with advanced disease stages, with 33% and 27% falling into intermediate (4-5 points) and high (≥6 points) TRI-SCORE categories, respectively. Patient profiles were broadly consistent with those in TRIGISTRY, although left ventricular, hepatic and renal dysfunction were less commonly encountered. CONCLUSION: These findings demonstrate the widespread adoption of the TRI-SCORE through free, user-friendly digital platforms and suggest its potential utility as a tool to monitor disease stage when considering interventions in patients with TR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyDecision Support TechniquesMobile ApplicationsTricuspid ValveHumansFemaleRisk AssessmentAgedPredictive Value of TestsRisk FactorsSeverity of Illness IndexMiddle AgedMalePrognosisDigital HealthClinical Decision-MakingAged, 80 and over

Stichwörter der Autor:innen

DigitalGuidelinesManagementTRI-SCORETricuspid regurgitation

Autor:innen und Institutionen

  • Department of Cardiology, Centre Cardiologique du Nord, 93200 Saint-Denis, France. Electronic address: dreyfusjulien@yahoo.fr.
  • Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Förderung

  • Edwards Lifesciences

Zitieren

APA

Dreyfus, J., & Messika-Zeitoun, D. (2026). Global adoption of TRI-SCORE digital tools for the risk stratification of patients with tricuspid regurgitation. Archives of Cardiovascular Diseases, 119(10), 637-640. https://doi.org/10.1016/j.acvd.2026.04.003

Vancouver

Dreyfus J, Messika-Zeitoun D. Global adoption of TRI-SCORE digital tools for the risk stratification of patients with tricuspid regurgitation. Archives of Cardiovascular Diseases. 2026;119(10):637-640. doi:10.1016/j.acvd.2026.04.003

BibTeX
@article{Dreyfus2026,
  author = {Dreyfus, Julien and Messika-Zeitoun, David},
  title = {Global adoption of TRI-SCORE digital tools for the risk stratification of patients with tricuspid regurgitation},
  journal = {Archives of Cardiovascular Diseases},
  year = {2026},
  volume = {119},
  number = {10},
  pages = {637--640},
  doi = {10.1016/j.acvd.2026.04.003}
}
Kostenlos starten →